The combined protective effect of a polyphenol-rich extract, isolated from Geranium sanguineum L. (PC), and a novel naturally glycosylated Cu/Zn-containing superoxide dismutase, produced from the fungal strain Humicula lutea 103 (HL-SOD), in the experimental infl uenza A virus infection (EIVI) in mice, induced with the virus A/Aichi/2/68 (H3N2), was investigated.
Introduction
Infl uenza is a major public health problem in the industrialized world because of its wide spread, high morbidity rate, and considerable social and economic implications. Infl uenza remains an important epidemic viral infection with the potential to cause pandemics. Recently, a novel H1N1 infl uenza virus spread fast in the human population, and the resulting pandemia has already proved to be a signifi cant and very costly cause of mortality and morbidity in the human population. Because recently available vaccines are not completely protective against infl uenza virus infection and no specifi c therapy of proven value currently exists for its severe forms, there is large interest in the development of new strategies for its control. The data on the combined inhibitory activity of natural and synthetic antiviral agents, though scarce, suggest that this could be a promising approach to the control of viral infections (Kurokawa et al., 1995; Musci et al., 1992; Weaver and Arou, 1998) and may be used successfully to increase the antiviral effi cacy of the individual compounds. Our group has a substantial experience in this fi eld of research (Gegova et al., 1993; Serkedjieva, 2000; Serkedjieva and Ivanova, 1997; Serkedjieva and Zgorniak-Nowosielska, 1993; Serkedjieva et al., 2003) .
We have studied intensively the mode of the anti-infl uenza virus activity of the semi-standardized polyphenol-rich extract isolated from Geranium sanguineum L. (PC). It was shown that its in vitro virus-inhibitory effect was specifi c and selective. PC affected the synthetic stages of A/Rostock viral replication; virus-specifi c RNA and protein synthesis were selectively inhibited (Serkedjieva and Hay, 1998) . We have demonstrated that the plant preparation markedly protected mice from mortality in the murine experimental infl uenza virus infection (EIVI) (Ivanova et al., 2005; Serkedjieva et al., 2007; Murzakhmetova et al., 2008) . PC interfered with the infection alternatively through enhancement and restoration of the host im-mune response (Ivanova et al., 2005) , regulation of the host lung protease activities (Serkedjieva et al., 2007) , and exhibition of antioxidant and radical scavenging properties (Murzakhmetova et al., 2008) . The variety of biological activities of the plant extract was related to the presence of large quantities of potential bioactive compounds, mainly polyphenols (Pantev et al., 2006) .
The fi ndings that reactive oxygen species (ROS) play an important role in infl uenza infection pathogenesis (Akaike et al., 1996) suggest that the use of exogenic superoxide dismutase (SOD) could be a new approach for the treatment of the disease (Oda et al., 1989) . We have established that Cu/Zn-containing SOD from Humicula lutea 103 (HL-SOD) increased the survival rate and prolonged the survival time in EIVI (Angelova et al., 2001) . It should be noted that HL-SOD is a naturally glycosylated enzyme, which could be isolated in few cases only. This characteristic is very important with regard to its in vivo pharmacological activity; in all probability its half life in plasma and blood is prolonged. The combined application of HL-SOD with rimantadine hydrochloride resulted in a synergistic amplifi cation of the protective effect (Serkedjieva et al., 2003) .
The aim of the present study was to investigate the combined protective effect of PC and HL-SOD on the lung injury of mice, induced by EIVI, as well as the combined effect on the production of ROS by alveolar macrophages (aMØ) and on the lung antioxidant enzymes SOD and catalase (CAT).
Material and Methods

Compounds
The medicinal plant Geranium sanguineum L. (Geraniaceae) has been introduced into the experimental fi eld of the Institute of Botany, Bulgarian Academy of Sciences, Sofi a, and a voucher specimen was deposited in the herbarium of the same institute (N SOM 5/86). The preparation of the extract has been described in detail before (Serkedjieva and Hay, 1998) . The polyphenol content of PC was controlled by thin layer chromatography and by quantitative determination of tannins, fl avonoids, and catechins (Pantev et al., 2006) .
Ascorbic acid (vitamin C, vit C) and trypsin were purchased from Sigma-Aldrich Chemie GmbH (Diesenhofen, Germany). Rimantadine hydrochloride (Rim) was obtained from Hoffman-La Roche Inc. (Nutley, NJ, USA).
Microorganism, cultivation and equipment
The fungal strain Humicula lutea 103 was used throughout and maintained at 4 ºC on beer agar, pH 6.3. Cultivation was performed in a 3-l bioreactor ABR-09, developed by CLBA, Bulgarian Academy of Sciences, Sofi a. The composition of the culture media was as described earlier (Angelova et al., 2001) . The preparation of the cell-free extract, analysis, purifi cation, and characterization of HL-SOD were as described in Angelova et al. (2001) .
Cell cultures and virus
Madin-Darby canine kidney (MDCK) cells were provided by Dr. I. Roeva, Institute of Microbiology, Bulgarian Academy of Sciences, Sofi a and were passaged as described in Serkedjieva et al. (2007) . The human infl uenza virus A/Aichi/2/68 (H3N2), adapted to mice lungs and maintained by passages in mice lungs and fertile hen's eggs was used (A/Aichi). The viral infectious titer was 10 5 TCID 50 /ml (50% tissue culture infectious doses/ ml), the hemagglutination titer was 1024. The viral stocks were stored at -80 ºC.
Mice
Male and female (16 -18 g), inbred ICR mice were obtained from the Experimental Animal Station, Bulgarian Academy of Sciences, Slivnitsa. They were quarantined 24 h prior to use and maintained on standard laboratory chow and tap water ad libitum for the duration of the studies. Experiments with animals were indispensable in investigations, concerning the treatment of infl uenza infection and the evaluation of their oxidative status. The number of experimental animals was reduced as much as possible, depending on statistical signifi cance. Refi nement of the tests with animals was achieved by careful planning of multifactor experiments. The animals were bred under standard conditions, accepted by the Bulgarian Veterinary Health Service. Specialized personnel took care of their welfare.
Mouse lung extracts
On days 6 and 9 post infection (p.i.) 3 mice of each group were anaesthetized with diethyl ether and, exsanguinated by section of the subclavian arteries. Lungs were removed aseptically, washed in cold phosphate buffered physiological saline (PBS) and blotted dry. Tissue pieces of about 1 g were disintegrated mechanically in ice-cold PBS and subsequently by an ultrasound disintegrator (MSE, Sheffi eld, England) for 3 min (interruption of sonication every 15 s). The homogenates were centrifuged (9,000 × g, 30 min, 4 ºC) and the supernatants were examined for SOD and CAT activities.
The SOD activity was assessed by the nitro blue tetrazolium (NBT) reduction method (Beauchamp and Fridovich, 1971) . The reaction mixture contained 56 mM NBT, 0.01 M methionine, 1.17 mM ribofl avin, 20 mM NaCN, and 0.05 M phosphate buffer, pH 7.8. Superoxide was measured through the increasing absorbance at 560 nm at 30 ºC after 6 min of incubation from the beginning of illumination. One unit of specifi c SOD activity was defi ned as the amount of enzyme protein required for inhibition of the reduction of NBT by 50% (A 560 ) and was expressed as units/mg of protein (U/mg protein).
The CAT activity was determined by monitoring the decomposition of 18 mM H 2 O 2 at 240 nm (Beers and Sizer, 1952) . One unit of activity was that, which decomposed 1 mM of H 2 O 2 /min/mg protein at 25 ºC and pH 7.0. The specifi c activity was given as U/mg protein.
Protein contents of the samples were estimated according to Lowry et al. (1951) .
aMØ were collected on days 6 and 9 p.i. by 5 washings of the broncho-alveolar cavity of 6 mice with 1 ml ice-cold HBSS. The phenotype of the cells was determined by light microscopy of cell populations immediately after being obtained.
The superoxide anion (O 2 -) release was measured using the SOD-inhibitable reduction of ferricytochrome c as previously described (Serkedjieva et al., 2007) . Cytochrome c reduction was measured at 550 nm in an ELISA reader (Organon Teknika, Salzburg, Austria). The amount of O 2 -produced per well was determined as the difference in cytochrome c reduction between wells without and with SOD.
The H 2 O 2 assay was based on horseradish peroxidase-mediated oxidation of phenol sulfonphthalein (phenol red) and was performed as previously described (Toshkova et al., 2006) . The reaction was read in an ELISA reader at 610 nm. H 2 O 2 concentrations were calculated using a standard curve (Werner, 2003) .
Viral infection and experimental design
The infection was induced under light diethyl ether anesthesia by intranasal (i.n.) inoculation of infl uenza virus A/Aichi. This virus causes hemorrhagic pneumonia in mice. To cause lethal infection, mice were infected with ten 50% lethal doses (LD 50 ) of the virus in a volume of 0.05 ml PBS per mouse. PC was applied nasally 3 h before viral infection in the dose 2.5 -10 mg/kg. HL-SOD was inoculated in the dose 125 -500 U/mouse/d either intravenously (i.v.) or intraperitoneally (i.p.) from the 4 th to 7 th day or from the 3 rd to 6 th day after viral challenge. Vit C was applied i.p. 24 and 2 h before and 24, 48, and 72 h after viral inoculation in the dose 100 mg/kg. Rim was used as a positive control (Dolin et al., 1982) and was applied orally (p.o.) 24 and 2 h before and 24, 48, and 72 h after viral challenge in the dose 40 mg/kg.
Mice were separated in 5 experimental groups: Group 1, mock-infected and PBS-treated -control healthy (CH); group 2, infl uenza A virus (IAV)-infected and PBS-treated -virus control (VC); group 3, IAV-infected and PC-treated (PC); group 4, IAV-infected and HL-SOD-treated (HL-SOD); group 5, IAV-infected and PC + HL-SODtreated (PC + HL-SOD). In the experiments with vit C, group 4 consisted of IAV-infected and vit Ctreated (vit C) mice and group 5 of IAV-infected and PC + vit C-treated (PC + vit C) mice. Following the challenge, mice were observed daily to monitor changes in body weight and to record death for 14 d.
Toxicity control for the combinations was run in parallel. After the end of the experiments surviving mice were sacrifi ced by cervical dislocation under diethyl ether anesthesia.
For the virological experiments the experimental groups consisted of 10 animals each, virus control groups (VC) consisted of 12 animals. Additional groups of 3 animals from each experimental group were sacrifi ced on day 7, their lungs were weighed, and lung consolidation was scored 0 -normal, 1 -25% consolidation, 2 -50% consolidation, 3 -75% consolidation, 4 -100% consolidation. Mice lungs were homogenized to a 10% suspension in PBS, and ten-fold dilutions were assayed for infectious virus in MDCK cells. Virus titers were expressed as log 50% tissue culture infectious doses/0.2 ml (log TCID 50 /0.2 ml) (Reed and Muench, 1938) . Virus controls were as described above.
The protective effects of PC, HL-SOD, Rim, and the combinations PC + HL-SOD and PC + vit C were estimated by the reduction of lung virus infectious titers, lung consolidation, lung weights, lung indices, and rates of mortality, the increase of indices of protection and prolongation of mean survival times (MST) as described in Serkedjieva and Ivanova (1997) . The index of protection (PI) was determined according to the equation PI = (PR -1)/PR · 100, where PR (ratio of protection) is M control /M experiment and M is the mortality. The combined effect was evaluated according to Webb (1966) . The effect of the combination (E 1,2 = PI 1,2 /100) and the effects of the individual substances (E 1 = PI 1 /100 and E 2 = PI 2 /100) are related in the equation E 1,2 = E 1 + E 2 -E 1 · E 2 ; the combined effect is synergistic if E 1,2 >, additive if E 1,2 =, and antagonistic if E 1,2 < E 1 + E 2 -E 1 · E 2 .
Statistical methods
Results from in vivo experiments are given either as arithmetic mean values or their ratios from 2 -4 experiments. For the biochemical parameters, 5 -7 measurements were made for every sample. Every experimental group was compared with the mean value of the group of healthy animals on the respective day of investigation. The results were analyzed statistically by the one-way analysis of variance (ANOVA). The two-tailed Student's t-test was used to evaluate differences in lung weights, lung virus titers, and lung scores. Fisher's exact test was used for comparison of the mortality rates. p < 0.05 was accepted for statistical signifi cance.
Results
Intranasal inoculation of the A/Aichi virus to mice produced a damaging infection of the lungs which, depending on the dose of the viral inoculum, was highly lethal to the animals. The experiments were carried out in conditions of 70 -80% mortality of virus control (5 LD 50 ). The pattern of the development of viral infectivity in the lungs of virus-infected mice (VIM) clearly showed that infectious titers were markedly reduced during the whole period of observation by the combined application of PC and HL-SOD (Fig. 1) .
The combined use of HL-SOD and PC in doses, which by themselves were ineffective or with low potency (1/4 -1/8 of the effective doses), led to a substantial growth of survival and resulted in increased protective effects, determined on the basis of the indices of protection. The calculated enhancement was of the synergistic type. On day 6 p.i., at the peak of infection, all infectious parameters -lung consolidation, lung virus titers, lung weights, mortality rates of infected animals -were reduced signifi cantly; lung indices were raised, and survival times markedly increased by drug combinations (Table I ). This tendency was observed also on day 9 p.i., the convalescent stage of infection. The combinations were well tolerated by the experimental animals and the improved protection was not associated with increased toxicity.
For comparative reasons the combined protective effect of PC and vit C, possessing antioxidant properties, was investigated. The results are presented in Table II . An enhancement of protection of the synergistic type was observed when vit C and PC were applied in the doses 2.5 and 100 mg/ kg, respectively. The MST was prolonged to 3.9 days. The combination of 100 mg/kg vit C and 1.25 mg/kg PC was indifferent and in any case the achieved survival rate was not signifi cantly different from that of VC. All lung parameters were ameliorated (Table II) . Furthermore we investigated the effect of a selected PC + HL-SOD combination (2.5 mg/kg and 125 U/mouse/d) on oxidative stress response. As a fi rst approach we studied the effect of the individual components and their combination on ROS generation from aMØ of VIM. EIVI induced an about 1.6-fold increase of O 2 -production on day 6 p.i. and an 1.8-fold increase on day 9 p.i., CH being (3.04 ± 0.09) nM O 2 -/10 6 cells for 1 h (Fig. 2A) . While PC treatment did not affect the generation of O 2 -, HL-SOD suppressed their accumulation. The superoxide release in VIM after PC + HL-SOD treatment was reduced and was brought to normal levels on both days of obser- The combined effect is synergistic if E 1,2 >, additive if E 1,2 = , and antagonistic if E 1,2 < E 1 + E 2 -E 1 · E 2 . E 1,2 = E 1 + E 2 -E 1 · E 2 , where E 1,2 = PI 1,2 /100, E 1 = PI 1 /100, and E 2 = PI 2 /100. vation. EIVI triggered also a marked enhancement of H 2 O 2 production (Fig. 2B) , peaking on day 6 p.i. [224% of CH, CH being (4.4 ± 0.12) nM H 2 O 2 /10 6 cells]. While PC did not change significantly the level of H 2 O 2 production at both time points, HL-SOD was more effective on day 6 p.i. PC + HL-SOD treatment noticeably reduced the excessive discharge, induced by EIVI, and led to normalization of the H 2 O 2 levels.
Furthermore we inspected the effect of PC, HL-SOD, and their combination on the lung antioxidant enzymes SOD and CAT. EIVI induced a slight increase of SOD activity on day 6 p.i., and its maximum was reached on day 9 p.i. [150% of CH, CH being (6.8 ± 1.06) U/mg protein] (Fig. 3A) . The maximum of CAT activity induced by EIVI was measured on day 6 p.i. [148% of CH, CH being (4.4 ± 0.55) U/mg protein]; on day 9 p.i. no raise of CAT levels was registered (Fig. 3B) . PC + HL-SOD treatment led to normalization of the enzyme levels.
Discussion
It has been shown that EIVI is accompanied by profound changes in cell/tissue metabolism, which lead to intensive generation of ROS (Akaike et al., 1996) . ROS are known to play a dual role during infl uenza infection. They have a part in pulmonary tissue damage, hypoxia, and toxicosis due to their toxic properties; on the other hand, they can induce apoptosis in virus-infected cells, thus contributing to the decrease in the total viral load. In this way ROS offer the fi rst line of defense against infection, preceding the alternative defense mechanisms of the organism (Arora and Houde, 1992) . The presented results together with our previous data (Murzakhmetova et al., 2008) show that infl uenza A/Aichi virus infection is accompanied with defi cits in antioxidant enzyme activities and an increase in ROS and lipid peroxidation (LPO) levels in the lungs, livers, and sera, which can be overcome through supplementation with antioxidants. Plant polyphenols acting as antioxidants also demonstrate protective effects during IAV-triggered oxidative stress (Kumar et al., 2005; Murzakhmetova et al., 2008) . It has been also demonstrated that treatment with SOD improves lung pathology and reduces lethality in IAV-induced pneumonia (Angelova et al., 2001; Oda et al., 1989) .
Because of their location at the alveolar air tissue interface, the aMØ are the fi rst line of cellular defense against infectious microorganisms that enter the lungs. Otherwise macrophages can contribute directly to IAV-induced lung pathology by releasing excessive amounts of reactive nitrogen intermediates and ROS. Recently O 2 -has been suggested to be related to the occurrence and exacerbation of interstitial pneumonia. H 2 O 2 plays an important role in host defense and oxidative biosynthetic reactions. To protect themselves against toxic radicals, cells have developed a variety of antioxidant defenses. These include enzymes such as SOD, which dismutates superoxide, CAT, which converts hydrogen peroxide into water and oxygen, and glutathione peroxidase, which destroys toxic peroxides (Akaike et al., 1996) .
In the present paper we wanted to test the hypothesis of the advantageous combined treatment of the murine A/Aichi EIVI with a plant polyphenol-rich preparation and a novel glycosylated fungal SOD.
As a fi rst approach we examined the effects of PC, HL-SOD, and their combination on ROS generation in aMØ. Though PC did not affect markedly the production of ROS during infection, applied in the dose of 2.5 mg/kg (Figs. 2A,  B) , previously we have shown that the preventive treatment with 10 mg/kg PC modulated the excessive generation of O 2 -and H 2 O 2 (Toshkova et al., 2006) . In addition, a benefi cial effect has been observed on the enhanced NO production. HL-SOD suppressed the generation of O 2 -. The combined PC + HL-SOD treatment further reduced the excessive discharge of O 2 -and even more dramatically the accumulation of H 2 O 2 and lead to normalization of ROS levels (Figs. 2A, B) .
We have found previously that the preventive treatment of VIM with PC (10 mg/kg), in addition to the decrease of ROS and NO generation from aMØ (Toshkova et al., 2006) , brought to normal the levels of malondialdehyde (MDA), used as a biomarker of LPO) in the lungs, livers and sera of VIM at each time point of observation (Murzakhmetova et al., 2008) . Of special interest is the antioxidant effect of PC in the lungs of VIM since lungs are the target organs of IAV infection. Furthermore, we inspected the effect of PC, HL-SOD, and their combination on the antioxidant enzymes SOD and CAT in the lungs of VIM. In alternative models of oxidative stress it has been observed that the failure of the host to induce enzyme expression according to its demand resulted in degeneration and cell death (Semrau et al., 1998) . EIVI induced a slight increase of SOD activity on day 6 p.i.; its maximum was reached on day 9 p.i. [150% of CH, CH being (6.8 ± 1.06) U/mg protein] (Fig. 3A) . The maximum of CAT activity induced by EIVI was measured on day 6 p.i. [148% of CH, CH being (4.4 ± 0.55) U/mg protein] (Fig. 3B) . The observed rise of SOD and CAT activities in VIM corresponded to the elevation of O 2 -and H 2 O 2 levels. However, the produced antioxidant enzymes obviously were not in suffi cient amounts to cope with the excessive generation of ROS (Fig. 2) . PC, applied in the dose of 2.5 mg/kg, did not affect the production of SOD and CAT during infection. Nonetheless we have observed that the preventive treatment with 10 mg/kg PC modulated the excessive generation of the two enzymes both in the lungs and livers of IAV-infected animals (unpublished). Similar results were obtained by Kumar et al. (2005) ; they detected a rise of lung antioxidant enzymes during EIVI and reported that oral supplementation with quercetin increased their pulmonary concentrations. The application of HL-SOD caused a reduction of lung SOD and CAT levels at each time point. PC + HL-SOD treatment reduced the activated enzyme levels to normal and thus evidenced the modulatory effect of the combination on the lung antioxidant enzymes (Fig. 3) .
The presented results confi rmed the free-radical character of EIVI and provided evidence for the benefi cial effect of the combined treatment with PC and HL-SOD. Thus, it could be speculated that the modulation of oxidative stress is an alternative mode of action of the combination in addition to its specifi c virus-inhibitory activity.
It has been found that PC showed also prooxidant characteristics (Murzakhmetova et al., 2008) . In the intact animals the level of MDA was increased by 30% in the lungs on days 6 and 9 p.i. and in the livers on day 6 p.i. Similar results have been observed in alternative assays: PC (10 mg/ kg) caused an increase of the generation of H 2 O 2 on day 2 and of O 2 on day 6 p.i. (Toshkova et al., 2006) . It is tempting to speculate that the prooxidant capacity of the plant extract at the early stages of infection could be part of the nonspecifi c defensive reaction of the organism before the development of the specifi c immune response. Both the prooxidant as well as the antioxidant effects could be important mechanisms of the host response modulation in EIVI. Although known for their antioxidant activities, rutin and quercetin, for instance, exhibit prooxidant effects in healthy animals (Kumar et al., 2005) . Hence, therapeutic strategies to modulate, but not totally obliterate, the generation of ROS, and so reduce the impact of the cellular injury in the lung, would appear to have considerable benefi t.
Our results are in agreement with the accumulating evidence that a great number of aromatic, medicinal, and other plants contain chemical compounds exhibiting antioxidant properties, and some of their physiological effects are actually due to their antioxidative activities. In this respect a particular interest has been given to plant polyphenols. The natural polyphenols have an ideal structure for capturing free radicals, and their antioxidant activity surpasses the effect of known antioxidants such as the vitamins A and E (Murzakhmetova et al., 2008 and references cited therein).
The effect of the combination of the plant polyphenol-rich extract and the fungal SOD on the inspected biochemical parameters was studied in parallel with the virological factors of the infection, e.g. rate of mortality, mean survival time, infectious lung virus titer and consolidation of the lungs, lung weights, and lung indices ( Table I ). In additional experiments clear evidence of protection was observed for animals receiving PC + HL-SOD treatment; a signifi cant reduction of mortality rates (IP = 52.6 -76.4) and marked prolongation of MST (up to +5.2 days) was achieved. Lung infectious virus titers (Δlog TCID 50 /ml = 3.9 -5.7), lung weights, and lung indices were reduced; lack of body weight increase was reversed, lung lesions as shown by macroscopic and microscopic examination were markedly alleviated. Light microscopy examination of mice lungs revealed reduction of the hemorrhages and alveolar edema; no cells of the lymphoid type were observed. The protective activity of the combinations in the mouse model was associated with reduction in lung virus titers and pneumonitis, as well as with improved body weight during the infection. Thus alleviation of major infl uenza symptoms was attained.
It should be noted that while the 4-fold intraperitoneal treatment with as much as 1000 U/ mouse/d HL-SOD was not effi cient (not shown), a 4-to 8-fold reduced dose enhanced the protective effi cacy of PC, applied in otherwise ineffi cient doses (2.5 and 1.25 mg/kg).
For comparative reasons the combined protective effect of PC and vitamin C was investigated (Table II ).
An enhancement of protection of the synergistic type was observed when vit C and PC were applied in the doses 2.5 and 100 mg/kg, respectively. All lung parameters were ameliorated (Table  II) . It has been suggested that in addition to its antioxidant properties vitamin C may affect the incidence and severity of the common cold and other respiratory infections (Hemila, 2004) . Li et al. (2006) showed that vitamin C was required for an adequate immune response in limiting lung pathology after IV infection.
The infl uenza virus, like other viruses, depends on its host cell, and thus cellular functions and mechanisms essential for viral replication might be suitable targets for antiviral therapy. As a result viral growth could be affected independent of the type, strain, and antigenic properties of the invading virus.
In conclusion, the obtained results clearly demonstrated that the fungal Cu/Zn-containing SOD enhanced the therapeutic effi cacy of the plant polyphenol-rich extract and outlined the antioxidant and radical scavenging properties of their combinations; the combinations benefi cially modulated the oxidative stress response in IAVinduced pneumonia. This alternative mechanism of action by all means contributed to the overall protective effect in lethal murine EIVI in addition to their specifi c virus-inhibitory activity.
The present results indicate that tissue damage during infl uenza virus infection may greatly be reduced by combined antiviral therapy and in general by the benefi cial role of the combined use of viral inhibitors with diverse mechanisms of action. This could be explained with the effective integration of different functions in the control of the infection. Thus, the appropriate combined use of antiviral agents, among them antioxidants, is a promising approach for the control of the disease.
